Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
The Netherlands Journal of Medicine|August 1, 1995
Early detection and treatment of oesophageal and gastric cancer. The Rotterdam Oesophageal Tumour Study GroupP D Siersema, J Dees, H W Tilanus, et al.British Journal of Cancer|June 11, 1999
Phase I study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced oesophageal cancerA van der Gaast, T C Kok, L Kerkhofs, et al.British Journal of Cancer|March 1, 1994
Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1A van der Gaast, C H Schoenmakers, T C Kok, et al.Cancer|July 1, 1993
Influence of radiologically and cytologically assessed distant metastases on the survival of patients with esophageal and gastroesophageal junction carcinoma. The Rotterdam Esophageal Tumor Study GroupH van Overhagen, M Y Berger, H Meijers, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Prognostic significance of tissue polypeptide-specific antigen (TPS) in patients with advanced non-small cell lung cancerA van der Gaast, C H Schoenmakers, T C Kok, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Randomised phase II trial of carboplatin and iproplatin in advanced urothelial cancerR de Wit, M Tesselaar, T C Kok, et al.Anti-Cancer Drugs|July 19, 2001
Phase II study of the combination cisplatin, etoposide, 5-fluorouracil and folinic acid in patients with advanced squamous cell carcinoma of the esophagusM B Polee, T C Kok, P D Siersema, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A phase I study of local treatment of liver metastases with recombinant tumour necrosis factorG P van der Schelling, J N IJzermans, T C Kok, et al.British Journal of Cancer|December 1, 1992
Distinction of two different classes of small-cell lung cancer cell lines by enzymatically inactive neuron-specific enolaseT A Splinter, C F Verkoelen, M Vlastuin, et al.British Journal of Cancer|September 1, 1996
Cisplatin and etoposide in oesophageal cancer: a phase II study. Rotterdam Oesophageal Tumour Study GroupT C Kok, A Van der Gaast, J Dees, et al.Pageof 4